LANXESS: Update on ENVALIOR Stake
- Advent HoldCo will in 2026 not take over LANXESS’ shares in the ENVALIOR joint venture
- LANXESS remains solidly financed; repayment of the bond due in October already secured
Advent HoldCo will in 2026 not acquire the LANXESS stake in the ENVALIOR joint venture that LANXESS had tendered in September 2025. Advent HoldCo has now informed the specialty chemicals company accordingly, referring to its contractually agreed financing condition. As a result, the additional tender and purchase periods for LANXESS’ shares in ENVALIOR in the years 2027 and 2028 now apply, as described in the ad hoc announcement of September 23, 2025.
LANXESS will continue to play an active role as a committed joint venture partner in shaping the expected positive development of ENVALIOR. According to LANXESS, key drivers of this development include the recovery of the market, synergy effects between the two companies brought into the joint venture as well as consolidation among direct competitors.
Even without proceeds from a sale of its ENVALIOR stake in 2026, LANXESS is solidly financed. The company holds a strong cash position as well as undrawn, firmly committed credit lines totaling more than EUR 1.35 billion. Therefore, repayment of the bond maturing in October 2026 is already ensured. The financing instruments are not subject to any financial covenants.
In addition, LANXESS continues to have unrestricted and broad access to the debt capital markets.
Reducing financial debt remains a high priority for LANXESS.
LANXESS will publish its financial results for the year 2025 on March 19, 2026.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.
You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.
